FDA Drug · D-0194-2025

Acetaminophen Regular Strength, 325 mg, 100 Tablets per bottle, Akron Pharma, Inc., 373 RT US 46 W Building E, Suite 117, Fairfield, NJ 07004, NDC 71399-8024-01 .

Class III · Ongoing

Labeling: Not Elsewhere Classified: Tablets/Capsules imprinted with wrong ID.

Affected lots / codes — check yours against thisLot #: KDT0124001, Exp 08/31/2026

Recalling firm: Akron Pharma, Inc., Fairfield, NJ
Classification: Class III (unlikely to cause harm)
Status: Ongoing
Quantity: 6429 bottles
Distribution: Nationwide in the US
Recall initiated: December 12, 2024
Classified: January 10, 2025
Initiation: Voluntary: Firm initiated

Official source. This record is published by the U.S. FDA through the openFDA enforcement database. View the unmodified government record:
https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0194-2025%22

Important. Recalls target specific lots and codes — compare the affected lots above against your own product. This page reproduces public FDA data for readability; EveryRecall is independent and not affiliated with the FDA.

Check this brand across all 8 databases →